Approval · Notice of Compliance 4449 · 1996
HYPERHEP: Notice of Compliance 4449
Issued March 26, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4449
- Date
- March 26, 1996
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYPERHEP | 02205955 | — |
Medicinal ingredients
- HEPATITIS B IMMUNOGLOBULIN (HUMAN) 217 UNIT per ML